| 1. |
?董力,石應康,鄧承祺,等.應用國際標準比值監測心臟機械瓣膜替換術后抗凝治療.中華胸心血管外科雜志,1999,15 (3):41-43.
|
| 2. |
Gan GG,Teh Alan,Goh KY,et al.Racial background is a determinant factor in the maintenance dosage of warfarin.Int J Hematol,2003,78 (1):84-86.
|
| 3. |
Ouirke W,Cahill M,Perera K,et al.Warfarin prevalence,indications for use and haemorrhagic events.Ir Med J,2007,100 (3):402-404.
|
| 4. |
于景榮,馬騰云.華法林的臨床應用.吉林醫學,2008,10 (20):1811-1812.
|
| 5. |
董力,石應康,田子樸,等.心臟機械瓣膜替換術后低強度抗凝治療.中華外科雜志,2003,1 (4):250-252.
|
| 6. |
Van Nooten GJ,Van Belleghem Y,Caes F,et al.Lower-intensity anticoagulation for mechanical heart valves:a new concept with the ATS bileaflet aortic valve.J Heart Valve Dis,2003,12 (4):495-502.
|
| 7. |
張遠超,喻莉,陳寶鈞.華法林在心臟機械瓣膜置換術后抗凝治療療效觀察.中華實用診斷與治療雜志,2008,22 (11):858-859.
|
| 8. |
Geno A,Turp A G,Steidl L,et al.Comparison of a daily fixed 2.5 mg warfarin dose with a 5mg international normalized ratio adjusted,warfarin dose initially following heart valve replacement.Am J Cardiol,2001,88 (1):40.
|
| 9. |
殷君太,朱家麟,王志農,等.心瓣膜置換術后血漿華法林濃度的動態變化及其臨床意義.中國胸心血管外科臨床雜志,1999,6 (4):239-241.
|
| 10. |
Zhou XM,Zhuang W,Hu JG,et al.Lower-Dose anticoagulation in Chinese patients with mechanical heart valves.Asian Cardiovasc Thorac Ann,2005,12 (4):341-344.
|
| 11. |
孟旭,李金鐘,劉巖,等.人工機械瓣膜置換術后口服抗凝藥的抗凝治療強度標準.中華心血管病雜志,2004,32 (7):618-621.
|
| 12. |
何小平,秦太昌,王志斌.心臟瓣膜置換術后服用華法林抗凝治療的臨床觀察.中西醫結合心腦血管病雜志,2010,8 (5):616-617.
|
| 13. |
徐志云,張寶仁,朱家麟,等.國產側傾碟瓣二尖瓣替換10年以上隨訪.中華胸心血管外科雜志,1995,11 (3):135-137,190.
|
| 14. |
Choi JB,Park HK,Kim KH,et al.Predictive factors of sustained sinus rhythm and recurrent atrial fibrillation after the maze procedure.Korean J Thorac Cardiovasc Surg,2013,46 (2):117-123.
|
| 15. |
Nakamura T,Izutani H,Sawa Y.Mid-term outcomes of the modified Cox-maze procedure for elderly patients:a risk analysis for failure.Interact Cardiovasc Thorac Surg,2011,12 (6):924-928.
|
